インターロイキン 6 - dofaq.co
Roche’s IL-6 Blocker Clears Phase III Bar, Still Falls Short of Expectations
BioSpace - 22 Mar 2024
Roche’s IL-6 Blocker Clears Phase III Bar, Still Falls Short of Expectations ...
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Nature.com - 14 Feb 2024
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer ...
Regulatory T cells require IL6 receptor alpha signaling to control skeletal muscle function and regeneration
ScienceDirect.com - 03 Oct 2023
Regulatory T cells require IL6 receptor alpha signaling to control skeletal muscle function and regeneration ...
Roche's IL-6 immunoassay wins CE mark for diagnosing neonatal sepsis
Medical Device Network - 18 Oct 2023
Roche's IL-6 immunoassay wins CE mark for diagnosing neonatal sepsis ...
Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing ...
Nature.com - 21 Sep 2023
Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing ... ...
Transcriptomic signatures of feline chronic gingivostomatitis are influenced by upregulated IL6 | Scientific Reports
Nature.com - 18 Aug 2023
Transcriptomic signatures of feline chronic gingivostomatitis are influenced by upregulated IL6 | Scientific Reports ...
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
Nature.com - 03 Jan 2024
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia ...
COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs | Scientific Reports
Nature.com - 12 Jun 2023
COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs | Scientific Reports ...
Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human ...
Nature.com - 13 Dec 2023
Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human ... ...
IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation
Nature.com - 15 Jun 2021
IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation ...
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology
Nature.com - 01 Jul 2021
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology ...
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
Nature.com - 08 Jun 2021
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40 ...
Is IL-6 a key cytokine target for therapy in COVID-19?
Nature.com - 13 Apr 2021
Is IL-6 a key cytokine target for therapy in COVID-19? ...
Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions | Scientific Reports
Nature.com - 24 Feb 2023
Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions | Scientific Reports ...
Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation | Scientific Reports
Nature.com - 14 Dec 2020
Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation | Scientific Reports ...
IL-6 and the dysregulation of immune, bone, muscle, and metabolic homeostasis during spaceflight | npj Microgravity
Nature.com - 04 Dec 2018
IL-6 and the dysregulation of immune, bone, muscle, and metabolic homeostasis during spaceflight | npj Microgravity ...
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers
Nature.com - 15 Jun 2022
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers ...
Targeting IL-6 trans-signalling: past, present and future prospects
Nature.com - 17 Apr 2023
Targeting IL-6 trans-signalling: past, present and future prospects ...
IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming ...
Nature.com - 29 Sep 2021
IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming ... ...